Vahva vertailukausi, johon 5% kasvua liikevaihtoon.
EPS ja myös vapaa kassavirta miinuksella. Ilmeisesti AI-palveluiden kehitystyö vie osansa 
.
ARR puolestaan kasvoi hyvin 21%
Second quarter: 1st April – 30th June 2024
- Revenue increased by 5 per cent against a strong comparator to generate total sales of EUR 4.0m (EUR 3.8m). This growth was achieved in the Lifecare division (10 per cent) but was offset by a contraction within the Wellness division (2 per cent).
- Subscription revenue increased 21 per cent (€0.6m) to €3.2m and now makes up 82 per cent of total group revenue, a significant increase from the prior year’s comparative of 71 per cent.
- Adjusted EBITDA of EUR 0.9m (EUR 1.0m) was generated resulting in an Adjusted EBITDA margin of 23 per cent (25 per cent).
- Adjusted operating loss of EUR 0.3m (profit EUR 0.1m) was generated resulting in a margin of -7 per cent (1 per cent).
- Adjusted ordinary and diluted profit per share totalled EUR (0.02) (EUR 0.00).
- Cashflow generated from operations before the payment of adjusting items equalled EUR 0.4m (EUR 0.5m).
- Free cash flow for the quarter was a net outflow of EUR 0.8m (outflow EUR 0.6m).
Uutena julkaisuna jo aiemmin mainostettu AI-kehityksen tulos:
AI-ohjattua itsehoitoa - arvostuskertoimet vähintään pitäisi nyt triplaantua 
Champion Health Plus, a division of Physitrack Plc, proudly announces the launch of its cutting-edge AI-driven musculoskeletal care platform, Nexa. This innovative platform offers self-triage, self-management, and seamless escalation to care professionals, providing comprehensive care through a national partner network of over 850 clinics across the United Kingdom.